QOL Medical LLC
Paul Capozello has a work experience spanning over several companies and roles. Paul started their career at TAP Pharmaceuticals in 2003 as a Senior Sales Representative and worked there until 2007. Paul then joined Prometheus Laboratories Inc., a Nestlé Health Science Company, where they served as a Senior Territory Sales Specialist from 2007 to 2012. Following that, they worked at EndoChoice as a Senior Territory Sales Manager from 2012 to 2015. Currently, they are employed at QOL Medical LLC, where they initially worked as a Regional Sales Manager for the Southeast region from 2015 to 2021. Presently, they hold the position of National Sales Director at QOL Medical LLC, starting in November 2021.
Paul Capozello earned a Bachelor of Arts (B.A.) degree in International Relations from Saint Joseph's University from 1994 to 1998.
This person is not in any offices
QOL Medical LLC
OL Medical is a specialty biopharmaceutical company dedicated to improving the quality of life for patients with rare diseases, for their families, and for the physicians and caregivers who support them.QOL Medical is a patient-centric company founded in 2003 to focus on the acquisition and commercialization of orphan products in underservedmarkets. QOL Medical ensures an expanded clinical awareness and patient access for improved quality of life in the treatment of rare and orphan diseases. The Company currently markets two FDA-approved products: Sucraid® (sacrosidase) Oral Solution and Ethamolin® (Ethanolamine Oleate) Injection, 5%.QOL Medical, in its commitment to assuring safe and effective products for our customers, uses validated procedures through audited and approved vendors for manufacturing, testing, and distribution. Additionally, QOL Medical has procedures for product monitoring, customer complaints, investigations into nonconformities, and change control.